Skip to content

Dafodil™

by Meril Life Sciences Pvt. Ltd. India EUDAMED

Ref DDL33M

EMDN P070301010202

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number1434-MDR-021/2025 Date29 Aug 2025IssuedStatusActive expires 28 Aug 2030

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/MDR Active

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)

Specification

EUDAMED · synced 22 Oct 2026

Device Name
Dafodil™ Pericardial Bioprosthesis Valve
Model / Reference
DDL33M
Primary DI / UDI-DI
18904224951188
Basic UDI-DI
89042249PBE8
Direct Marketing DI
18904224951188
EMDN Code
P070301010202 Stented mitral biological valves for surgical implant - non-valve tissue of animal origin
Device Class
Class III
Market of Registration
Germany

Manufacturer details

EUDAMED SRN
IN-MF-000008308
Authorised representative
Obelis s.a. BE-AR-000000106

Other devices from Meril Life Sciences Pvt. Ltd.

See all devices from Meril Life Sciences Pvt. Ltd. →

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
  • Implantable
  • Animal Tissues
Other properties (10)
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED f7819103-cfd6-4e7e-8251-a30466447d11 61 fields · synced 22 Oct 2026